Arvinas, Inc.
ARVNNASDAQHealthcare● Active
$7.43
+$0.01(+0.07%)
Market Cap$479069895
P/E Ratio—
52W High$14.51
52W Low$6.06
Arvinas, Inc. (ARVN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARVN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.90
Est. -$0.95 · +5.3%
Revenue
$0.02B
Est. $0.02B · -6.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
ARVN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.33 | — | — | — | $0.06B | — |
| ▲ Q2 FY2026 | May 12, 2026 | -$0.95 | -$0.90 | +5.3% | $0.02B | $0.02B | -6.1% |
| ▼ Q1 FY2026 | Feb 24, 2026 | -$0.55 | -$1.10 | -100.0% | $0.01B | $0.04B | -74.5% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.75 | -$0.48 | +36.0% | $0.04B | $0.04B | +12.4% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.87 | -$0.84 | +3.5% | $0.02B | $0.03B | -10.4% |
| ▲ Q2 FY2025 | May 1, 2025 | -$0.86 | $1.14 | +232.6% | $0.19B | $0.04B | +346.3% |
| ▲ Q1 FY2025 | Feb 11, 2025 | -$1.07 | -$0.63 | +41.1% | $0.06B | $0.04B | +39.2% |
| ▲ Q4 FY2024 | Oct 30, 2024 | -$0.88 | -$0.68 | +22.7% | $0.10B | $0.06B | +72.1% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.33
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
-$0.90
EPS Est.
-$0.95
EPS Surpr.
+5.3%
Revenue
$0.02B
Q1 FY2026
Feb 24, 2026Miss
EPS Actual
-$1.10
EPS Est.
-$0.55
EPS Surpr.
-100.0%
Revenue
$0.01B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.48
EPS Est.
-$0.75
EPS Surpr.
+36.0%
Revenue
$0.04B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.84
EPS Est.
-$0.87
EPS Surpr.
+3.5%
Revenue
$0.02B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$1.14
EPS Est.
-$0.86
EPS Surpr.
+232.6%
Revenue
$0.19B
Q1 FY2025
Feb 11, 2025Beat
EPS Actual
-$0.63
EPS Est.
-$1.07
EPS Surpr.
+41.1%
Revenue
$0.06B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
-$0.68
EPS Est.
-$0.88
EPS Surpr.
+22.7%
Revenue
$0.10B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-2.94 | $-0.88 | $0.07 | 4 |
| Q3 FY2027 | $-3.07 | $-0.92 | $0.07 | 4 |
| Q2 FY2027 | $-3.22 | $-0.97 | $0.08 | 4 |
| Q1 FY2027 | $-3.21 | $-0.96 | $0.07 | 4 |
| Q4 FY2026 | $-2.63 | $-0.79 | $0.06 | 4 |
| Q3 FY2026 | $-1.04 | $-0.77 | $-0.14 | 10 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.1B | 5 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q4 FY2026 | $0.0B | $0.0B | $0.1B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.1B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +5.3% | $9.66 | $9.57 | -0.93% |
| ▼ Q1 FY2026 | Feb 24, 2026 | -100.0% | $12.30 | $12.37 | +0.57% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +36.0% | $9.54 | $9.57 | +0.31% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +3.5% | $7.61 | $6.43 | -15.51% |
| ▲ Q2 FY2025 | May 1, 2025 | +232.6% | $9.62 | $7.23 | -24.84% |
| ▲ Q1 FY2025 | Feb 11, 2025 | +41.1% | $18.97 | $17.68 | -6.80% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +22.7% | $27.50 | $27.66 | +0.58% |
| ▲ Q3 FY2024 | Jul 30, 2024 | +31.9% | $27.78 | $27.09 | -2.48% |
Q2 FY2026-0.93%
Report Date
May 12, 2026
EPS Beat/Miss
+5.3%
Price Before
$9.66
Price After
$9.57
Q1 FY2026+0.57%
Report Date
Feb 24, 2026
EPS Beat/Miss
-100.0%
Price Before
$12.30
Price After
$12.37
Q4 FY2025+0.31%
Report Date
Nov 5, 2025
EPS Beat/Miss
+36.0%
Price Before
$9.54
Price After
$9.57
Q3 FY2025-15.51%
Report Date
Aug 6, 2025
EPS Beat/Miss
+3.5%
Price Before
$7.61
Price After
$6.43
Q2 FY2025-24.84%
Report Date
May 1, 2025
EPS Beat/Miss
+232.6%
Price Before
$9.62
Price After
$7.23
Q1 FY2025-6.80%
Report Date
Feb 11, 2025
EPS Beat/Miss
+41.1%
Price Before
$18.97
Price After
$17.68
Q4 FY2024+0.58%
Report Date
Oct 30, 2024
EPS Beat/Miss
+22.7%
Price Before
$27.50
Price After
$27.66
Q3 FY2024-2.48%
Report Date
Jul 30, 2024
EPS Beat/Miss
+31.9%
Price Before
$27.78
Price After
$27.09
Avg Beat Reaction-7.10%
Avg Miss Reaction+0.57%
Beat Rate7 / 8 quarters
Largest Move-24.84% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARVN ends December
Arvinas, Inc. (ARVN) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.90 — beating the analyst consensus of $-0.95 by +5.3%. The next ARVN earnings date is expected around September 1, 2026.
Each quarter, investors track ARVN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARVN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARVN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARVN earnings · 5 questionsArvinas, Inc.'s next earnings report is expected around September 1, 2026. ARVN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARVN historically reports after market close (AMC).
ARVN earnings datewhen is ARVN earningsARVN next earnings datewhen does ARVN report earningsARVN earnings calendar
▸ Source: FMP · Arvinas, Inc. SEC filings · US GAAP · Arvinas, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026